Cargando…
Patient-derived xenograft models in musculoskeletal malignancies
Successful oncological drug development for bone and soft tissue sarcoma is grossly stagnating. A major obstacle in this process is the lack of appropriate animal models recapitulating the complexity and heterogeneity of musculoskeletal malignancies, resulting in poor efficiency in translating the f...
Autores principales: | Lu, Wan, Chao, Tu, Ruiqi, Chen, Juan, Su, Zhihong, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913806/ https://www.ncbi.nlm.nih.gov/pubmed/29688859 http://dx.doi.org/10.1186/s12967-018-1487-6 |
Ejemplares similares
-
Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma
por: Tracey, Andrew T., et al.
Publicado: (2020) -
Clinical characteristics and prognostic factors of malignant fibrous histiocytoma of bone: a SEER population-based study
por: Qi, Lin, et al.
Publicado: (2020) -
Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017) -
Patient-derived xenograft models in hepatopancreatobiliary cancer
por: Pan, Binhua, et al.
Publicado: (2022) -
The ongoing trends of patient‐derived xenograft models in oncology
por: Zhuo, Jianyong, et al.
Publicado: (2020)